Goldman M P, Fitzpatrick R E
Department of Dermatology, University of California School of Medicine, San Diego 92037, USA.
Dermatol Surg. 1995 Aug;21(8):685-7. doi: 10.1111/j.1524-4725.1995.tb00270.x.
Erythematous and hypertrophic scars may occur after surgical procedures. This paper describes a novel technique for their resolution.
The purpose of this paper is to describe long-term results of treating erythematous, hypertrophic scars with the flashlamp-pumped pulsed dye laser (FLPDL).
Forty-eight patients who presented with erythematous/hypertrophic scars were treated with the FLPDL with or without intralesional triamcinolone. Patients were evaluated by physicians on a 25% increment of objective improvement.
Seventy-three percent of scars appearing on the face for less than 1 year totally resolved in an average of 2.3 treatments. Twenty percent of scars on the face for greater than 1 year had a total resolution in 4.4 treatments with an average improvement of 88%. Scars on nonfacial areas for less than 1 year had a 25% incidence of total resolution over an average of 2.5 treatments with an average improvement of 81%. Scars in nonfacial distributions over 1 year of age had a 12% total resolution with an average 62% improvement over 2.2 treatments.
The FLPDL is a useful adjuvant in the treatment of erythematous, hypertrophic scars.
手术操作后可能会出现红斑性和增生性瘢痕。本文介绍了一种解决这些瘢痕的新技术。
本文旨在描述用闪光灯泵浦脉冲染料激光(FLPDL)治疗红斑性、增生性瘢痕的长期效果。
48例患有红斑性/增生性瘢痕的患者接受了FLPDL治疗,部分患者联合病灶内注射曲安奈德。医生以客观改善25%的增量对患者进行评估。
出现在面部且时间少于1年的瘢痕,73%在平均2.3次治疗后完全消退。出现在面部且时间超过1年的瘢痕,20%在4.4次治疗后完全消退,平均改善率为88%。非面部区域且时间少于1年的瘢痕,25%在平均2.5次治疗后完全消退,平均改善率为81%。非面部区域且时间超过1年的瘢痕,12%完全消退,在2.2次治疗后平均改善率为62%。
FLPDL是治疗红斑性、增生性瘢痕的一种有用辅助手段。